ALB and hepatocellular carcinoma: Among patients with advanced fibrosis (n = 163 with nine censored all-cause death), we conducted a Cox proportional hazard analysis based on age (> 60 years), sex (male), prior history of HCC, pre-treatment platelet count (< 10x 104/μL; suggestive of baseline advanced fibrosis), serum albumin at SVR, estimated glomerular filtration rate (eGFR) at SVR, and 4COL7-defined fibrosis progression SVR.